Literature DB >> 458631

Pharmacokinetics of heparin. II. Studies of time dependence in rats.

T D Bjornsson, G Levy.   

Abstract

The purpose of this investigation was to determine whether the time course of heparin activity (bioassayed heparin concentration) in plasma of rats during and after constant rate i.v. infusion of heparin can be predicted from the pharmacokinetic characteristics of a single i.v. bolus dose of heparin administered to the same animals. Five rats received a rapid i.v. injection of heparin, 320 to 517 U/kg, and on the following day, an i.v. infusion of heparin, 2.7 to 4.0 U/min/kg, for 10 to 11 hr. Heparin activity in plasma at the end of the infusion was about twice as high as predicted on the basis of the total clearance of the bolus dose. Even though the maximum heparin activity immediately after the bolus dose and at the end of the infusion were similar, the biologic half-life of heparin at the end of the infusion was about twice as long as that of the bolus dose. Apparently, the pharmacokinetics of heparin are time dependent. This may explain, at least in part, the clinical observation that heparin infusion rate must often be reduced after the initial days of therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 458631

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

Review 1.  Revisiting the Pharmacology of Unfractionated Heparin.

Authors:  Abdallah Derbalah; Stephen Duffull; Fiona Newall; Katie Moynihan; Hesham Al-Sallami
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

2.  Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route.

Authors:  Yiwei Qi; Ganlin Zhao; Dongfang Liu; Zachary Shriver; Mallik Sundaram; Shiladitya Sengupta; Ganesh Venkataraman; Robert Langer; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-29       Impact factor: 11.205

Review 3.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

4.  Antibody-modified conduits for highly selective cytokine elimination from blood.

Authors:  J Brian McAlvin; Ryan G Wylie; Krithika Ramchander; Minh T Nguyen; Charles K Lok; Morgan Moroi; Andre Shomorony; Nikolay V Vasilyev; Patrick Armstrong; Jason Yang; Alexander M Lieber; Obiajulu S Okonkwo; Rohit Karnik; Daniel S Kohane
Journal:  JCI Insight       Date:  2018-07-12

5.  The recombinant plant Bauhinia bauhinioides elastase inhibitor reduces rat thrombus without alterations in hemostatic parameters.

Authors:  Cleide Oliveira; Mayara Vioto Valois; Tatiana Fontes Ottaiano; Antonio Miranda; Daiane Hansen; Misako Uemura Sampaio; Maria Luiza Vilela Oliva; Francisco Humberto de Abreu Maffei
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.